Transformative Computational Biology Grant Program

Transformative Computational Biology Grant Program is sponsored by Biswas Family Foundation (in partnership with Milken Institute SPARC). This program supports multidisciplinary research teams utilizing computational tools and artificial intelligence to drive translational impact in clinical settings for diagnosis and treatment.

Biswas Family Foundation Transformative Computational Biology Grant Awardees | Milken Institute Biswas Family Foundation Transformative Computational Biology Grant Awardees The Biswas Family Foundation and the Milken Institute are pleased to announce the five research teams selected to receive funding in the first cycle of the Transformative Computational Biology Grant Program .

Almost $14 million has been awarded to teams using computational tools across a range of focus areas including diagnosis of cardiovascular disease, precision oncology therapies, enhancement of clinical datasets, and drug repurposing systems. Many of the awarded studies have incorporated multidisciplinary collaborators to address gaps in translational research for enhanced integration of computational tools in clinical care.

Research studies will run for two or three years.

AI for Genomic Medicine: Circuitry, Treatment, Personalization Manolis Kellis, PhD , professor of computer science, Massachusetts Institute of Technology Co-Investigators: Brad Pentelute, PhD and Marinka Zitnik, PhD This project aims to support the integration of single-cell spatial sequencing with rapid machine learning approaches to generate a shortlist of target genes for precision therapeutics in metastatic melanoma.

The high-throughput discovery loop will help advance biomarker selection, de novo drug synthesis, and drug repurposing, which is essential for more effective cancer therapeutics.

A Chatbot Assistant for Genetic Diagnosis and Interpretation of Common and Rare Cardiovascular Diseases Anshul Kundaje, PhD , associate professor of genetics and computer science, Stanford University Co-Investigator: Jesse Engreitz, PhD This project aims to accelerate the diagnosis of patients with cardiovascular diseases by developing a chatbot interfaced with genomic knowledge graphs.

In the clinical diagnostic workflow, the impact of genomic mutations is unknown in many cardiovascular diseases, so genomic knowledge graphs populated by machine learning models trained on multiple types of data can improve the diagnostic process.

Biswas Center for Transformative Computational Cancer Biology Katherine Pollard, PhD , director of data science and biotechnology, Gladstone Institutes Co-Investigators: Alex Marson, MD, PhD, Barbara Engelhardt, PhD, Catherine Tcheandjieu Gueliatcha, DVM, PhD, Christina Theodoris, MD, PhD, Karin Pelka, PhD, Ryan Corces, PhD, Seth Shipman, PhD, and Vijay Ramani, PhD This project aims to support the development of personalized diagnosis and treatment for colorectal and skin cancers.

Machine learning models will be trained to predict how a patient’s genetic mutation can alter tumor cell biology to better understand the diverse pathways that drive cancer and to evaluate the effectiveness of candidate immunotherapies for more personalized treatments.

The MAIDA Initiative: Democratizing Global Medical Imaging Data Sharing for Safer and Fairer AI Pranav Rajpurkar, PhD , assistant professor of biomedical informatics, Harvard Medical School This project aims to collect medical imaging data from around the globe to facilitate the use of AI to analyze images and improve diagnosis and treatments.

The focus is on collecting chest X-rays and chest CT images for a variety of clinical settings. Developing an open data repository of medical images that is representative of diverse patient populations can help the deployment of AI tools that are more reliable, equitable, and inclusive.

CURE-Bench: Universal Benchmark for All-Disease Drug Repurposing Marinka Zitnik , PhD , assistant professor of biomedical informatics, Harvard Medical School This project aims to build CURE-Bench, a comprehensive all-disease benchmark for evaluating computational drug repurposing systems.

An international competition will help establish common tasks and datasets to promote the development, evaluation, and widespread use of AI models to identify clinically relevant drug repurposing hits. The goal is to develop a hub of pre-trained AI models and an accompanying evaluation framework to benchmark models across diseases and datasets.

Transformative Computational Biology: A Giving Smarter Guide Computational tools can rapidly identify patterns in vast volumes of biomedical and clinical data, leading to discoveries that can transform the diagnosis, treatment, and prevention of diseases to improve human health. While the scientific...

Biswas Family Foundation, Milken Institute Announce $15 Million in Funding for Research at the Intersection of AI and Health WASHINGTON, DC (March 12, 2024) — The Biswas Family Foundation, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), is pleased to announce the inaugural recipients of the...

Formerly Milken Institute Anxiety: A Giving Smarter Guide Anxiety is a natural and adaptive emotion that promotes vigilance against potential threats. However, anxiety that persists or is disproportionate to actual risk becomes dysfunctional and can impair daily functioning.

Request for Proposals: Ann Theodore Foundation Sarcoidosis Inhibitor of mTOR (SIM) Trial The Ann Theodore Foundation (ATF) is launching a new funding program to support the study of repurposed mechanistic target of rapamycin (mTOR) inhibitors as treatments for cutaneous sarcoidosis. This program will be executed in partnership...

Milken Institute, Ann Theodore Foundation Launch New Grant to Support Clinical Trial for Potential Sarcoidosis Treatment February 20, 2026 (Washington, DC)—The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future...

Schizophrenia Care: A Giving Smarter Guide Schizophrenia is a serious, chronic brain disorder affecting about 24 million people worldwide. Individuals with schizophrenia experience a variety of symptoms—most notably psychosis—and face significant challenges accessing the care they...

Ann Theodore Foundation Breakthrough Sarcoidosis Initiative, 2025–2026: Information Session The Ann Theodore Foundation, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), is accepting optional letters of intent through Thursday October 23, 2025, for its fifth round of...

Uterine Leiomyosarcoma: A Giving Smarter Guide This Giving Smarter Guide describes the current state of research, clinical practice, and treatment approaches for uterine leiomyosarcoma (uLMS) and identifies critical areas where philanthropy can significantly advance scientific knowledge...

Childhood Brain Cancer: A Giving Smarter Guide Pediatric brain cancer accounts for 16 percent of all new childhood cancer diagnoses, making it one of the most common cancer diagnoses in children and adolescents. It is also the leading cause of cancer death within this age group. Unlike...